NIKKEI 225
27,999.96 -175.94 (-0.62%) HANG SENG
20,009.93 -35.84 (-0.18%) CRUDE OIL
90.97 +0.21 (+0.23%) GOLD FUTURES
1,802.90 -2.30 (-0.13%) DOW
32,832.54 +29.04 (+0.09%) BTC-GBP
19,696.44 +57.12 (+0.29%)
Moderna, Inc. (MRNA)
| Previous close | 186.84 |
| Open | 185.20 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 180.09 - 190.28 |
| 52-week range | 115.61 - 497.49 |
| Volume | |
| Avg. volume | 5,427,683 |
| Market cap | 74.173B |
| Beta (5Y monthly) | 1.65 |
| PE ratio (TTM) | 10.96 |
| EPS (TTM) | 16.69 |
| Earnings date | 23 Feb 2022 - 28 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 220.67 |
- Zacks
MRNA vs. TECH: Which Stock Should Value Investors Buy Now?
MRNA vs. TECH: Which Stock Is the Better Value Option?
- Motley Fool
Prediction: This Bear Market Will Test Your Resolve In (At Least) 3 Ways
With the S&P 500 Index dipping as low as 23% within the past couple of months, we've hit the ballpark of bear market territory. Let's learn about three of the most common ways that bear markets create the very powerful temptation to sell so that you can resist the temptation when it calls. The most visible way that the bear market is likely to test investors' resolve is by demolishing the stocks of companies that were not too long ago put forward as high-flying success stories.
- Motley Fool
Where Will Moderna Be in 1 Year?
The vaccine maker has lost a little more than half of its value over the trailing 12-month period, partly because many investors think sales of its coronavirus vaccine, Spikevax, will drop off a cliff after this year. The coming 12 months could be crucial for Moderna, but what will they have in store for the company? In the U.S., the Biden Administration warned that a wave of the coronavirus is expected during the fall and winter.
